Adicet Bio
Latest round
- Series B
Last raised
- Sep 2019
Total raised
- $131M
Investors
- 13
About Adicet Bio
Founded in 2014 and based in California, US, Adicet Bio, Inc. is a biopharmaceutical company that discovers allogeneic gamma delta T cell therapies for cancer. The company was formed by CEO Chen Schor. In November 2016, Adicet Bio, Inc. acquired Applied Immune Technologies that develops immunotherapies directed to the intracellular proteome. In September 2020, Adicet Bio, Inc. merged with resTORbio, Inc., through which Adicet Bio, Inc. will become a publicly listed company on the NASDAQ stock exchange under the ticker symbol ACET. In January 2024, Adicet Bio, Inc.4 per share on the Nasdaq Global Select Market under the ticker symbol "ACET". Adicet Bio, Inc.32 million shares of common stock as part of the listing. The company’s scientific team is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. The company’s revenue is generated by conducting clinical trials to perform tumor-killing functions.
Who invested in Adicet Bio
13 investors across 2 rounds
See all investors in Adicet Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Adicet Bio
Who invested in Adicet Bio?
Adicet Bio has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Adicet Bio raised?
Adicet Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Adicet Bio last raise money?
Adicet Bio's most recent round on record is a Series B, in Sep 2019.
What does Adicet Bio do?
Founded in 2014 and based in California, US, Adicet Bio, Inc.
Where is Adicet Bio headquartered?
Adicet Bio is headquartered in Redwood City, US.
Which VCs invest in companies like Adicet Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Adicet Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Adicet Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.